Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

1.900

-0.14 (-6.9%)

Quarterly rpt on consolidated results for the financial period ended 30 Jun 2019

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2019
Quarter 2 Qtr
Quarterly report for the financial period ended 30 Jun 2019
The figures have not been audited

Attachments

Pharma Q2 2019.pdf
366.9 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2019

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Jun 2019
30 Jun 2018
30 Jun 2019
30 Jun 2018
$$'000
$$'000
$$'000
$$'000
1 Revenue
601,890
582,729
1,387,998
1,200,652
2 Profit/(loss) before tax
12,481
11,970
42,724
40,677
3 Profit/(loss) for the period
9,262
5,766
28,910
23,355
4 Profit/(loss) attributable to ordinary equity holders of the parent
9,281
5,394
28,898
22,980
5 Basic earnings/(loss) per share (Subunit)
3.56
2.08
11.09
8.84
6 Proposed/Declared dividend per share (Subunit)
2.50
4.00
8.50
9.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.9900
1.9600

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 23 Aug 2019
Category Financial Results
Reference Number FRA-19082019-00040




We found other announcement(s) you are probably looking for: